Pr. Hervé Avet-Loiseau, Director of CRCT's team 13 "Pharmacogenomics of multiple myeloma" and Director of IUCT-O's Unit "Genomics of Myeloma" is laureate of the 2017 Prize Rosen from the Fondation pour la Recherche Médicale (FRM) More information here.read more
The program "PhD PI3K Biology in Health in Disease", funded by the European Union (Horizon 2020 / Marie Sklodovska-Curie Program), aims to train the next generation of experts in the field of PI3Ks through the establishment of a European network of PhD students...read more
Better target the tumor and its immune environment to defeat multiple myeloma The ARC Foundation awarded a grant of 400,000 euros to Professor Hervé Avet-Loiseau for his work on multiple myeloma, the second most common malignant hemopathy (blood cancer), with more...read more
Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor Cholesterol and its transformation into cholesterol-5,6-epoxides (5,6-EC) was long suspected as contributing to breast cancer (BC)...read more
Julie Guillermet-Guibert, Director of CRCT’s team 17, has been awarded with the first “Prize Forcheurs Jean-Marie Lehn”.
This distinction, received from the Nobel Prize Jean-Marie Lehn